240 related articles for article (PubMed ID: 2969612)
21. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
22. The covalent interaction of C3 with IgG immune complexes.
Vivanco F; Muñoz E; Vidarte L; Pastor C
Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
[TBL] [Abstract][Full Text] [Related]
23. Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells.
Rask R; Rasmussen JM; Jepsen HH; Svehag SE
APMIS; 1989 Apr; 97(4):374-80. PubMed ID: 2524204
[TBL] [Abstract][Full Text] [Related]
24. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
25. The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA.
Marzocchi-Machado CM; Polizello AC; Azzolini AE; Lucisano-Valim YM
Immunol Invest; 1999; 28(2-3):89-101. PubMed ID: 10484684
[TBL] [Abstract][Full Text] [Related]
26. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
27. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
28. Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells.
Medof ME; Lam T; Prince GM; Mold C
J Immunol; 1983 Mar; 130(3):1336-40. PubMed ID: 6218206
[TBL] [Abstract][Full Text] [Related]
29. Clearance kinetics of soluble pre-formed immune complexes containing IgM antibodies in normal and decomplemented rabbits.
Harkiss GD; Brown DL
Immunology; 1981 Feb; 42(2):297-306. PubMed ID: 7461732
[TBL] [Abstract][Full Text] [Related]
30. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
[TBL] [Abstract][Full Text] [Related]
31. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
32. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor.
Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP
J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863
[TBL] [Abstract][Full Text] [Related]
33. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
[TBL] [Abstract][Full Text] [Related]
34. Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b.
Currie MS; Rustagi PK; Wojcieszak R; Ziolkowski L; Ross GD; Logue GL
Blood; 1988 Mar; 71(3):786-90. PubMed ID: 3345346
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of iC3b binding to human polymorphonuclear leucocytes.
Gordon DL; Johnson GM; Hostetter MK
Immunology; 1987 Apr; 60(4):553-8. PubMed ID: 2953669
[TBL] [Abstract][Full Text] [Related]
37. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
38. Complement fixation by small, DNase-resistant DNA-anti-DNA immune complexes.
Horgan C; Emlen W
Mol Immunol; 1987 Feb; 24(2):109-16. PubMed ID: 3497335
[TBL] [Abstract][Full Text] [Related]
39. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
40. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
